Pages that link to "Q34165258"
Jump to navigation
Jump to search
The following pages link to 5-HT6 Receptor Ligands and their Antipsychotic Potential (Q34165258):
Displaying 10 items.
- Antipsychotic, antidepressant, and cognitive-impairment properties of antipsychotics: rat profile and implications for behavioral and psychological symptoms of dementia (Q33605869) (← links)
- ADN-1184 a monoaminergic ligand with 5-HT(6/7) receptor antagonist activity: pharmacological profile and potential therapeutic utility. (Q37585410) (← links)
- 5HT(6) receptor antagonists: a patent update. Part 1. Sulfonyl derivatives (Q38027891) (← links)
- Investigational drugs targeting 5-HT6 receptors for the treatment of Alzheimer's disease. (Q38627971) (← links)
- Dopamine and serotonin modulation of motor and non-motor functions of the non-human primate striato-pallidal circuits in normal and pathological states (Q39125374) (← links)
- Characterization and Reliability of [18F]2FNQ1P in Cynomolgus Monkeys as a PET Radiotracer for Serotonin 5-HT6 Receptors. (Q41037541) (← links)
- Design, synthesis and pharmacological evaluation of indolylsulfonamide amines as potent and selective 5-HT6 receptor antagonists (Q47786351) (← links)
- Preclinical evaluation of [18F]2FNQ1P as the first fluorinated serotonin 5-HT6 radioligand for PET imaging. (Q48479735) (← links)
- Low-dose prazosin in combination with 5-HT6 antagonist PRX-07034 has antipsychotic effects (Q50621504) (← links)
- Rigidized 1-aryl sulfonyl tryptamines: Synthesis and pharmacological evaluation as 5-HT6 receptor ligands (Q84493636) (← links)